Market Research Logo

Electroceutical Devices Global Market – Forecast To 2022

Electroceutical Devices Global Market – Forecast To 2022

The electroceuticals technology utilizes devices that bring about a change in the nervous system by modulating brain activity. The treatment delivered by neurostimulation devices brings about life changing transformation in patients who fail to respond to traditional approaches. The opportunities to development new therapies for a wide variety of neurological and psychological conditions are attracting a lot of companies, startups and investments. According to IQ4I analysis, the global electroceutical devices market is expected to grow at a double digit CAGR from 2015 to 2022. Factors driving the electroceutical devices market include, projected increase in patients with chronic pain, neurological diseases, psychiatric conditions, cardiology conditions, improvements in technology such as miniaturization, better battery technology, wearable, wireless micro-current stimulation are all contributing to growth of electroceutical devices market whereas shocking areas of neural tissue to stimulate the desired response, electrical devices have been clunky and imprecise, mode of action is not known so basically it is a trial and error method etc are the factors hampering the market growth. Advancement of technology with its wide application areas shows that electroceutical devices market has vast opportunities in the coming years.

Electroceutical devices market is segmented on the basis of technology as internal and external electroceutical devices. The internal electroceutical devices is classified into Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Pacemakers, Implantable Cardioverter Defibrillator (ICD), Cochlear Implants and Others with Gastric Electrical Stimulation (GES) and Respiratory Electrical Stimulation (RES)/Phrenic Nerve Stimulation (PNS). The external electroceutical devices are classified as Transcutaneous External Nerve Stimulation (TENS), External Pacemakers, External Defibrillators and Others (Tumour Treating Fields (TTF), Micro-current stimulation).

Based on the application the electroceutical devices market is segmented into Pain management, Central Nervous System (CNS), Gastroenterology/Urology, Hearing aids, Cardiology and other applications. Based on end-users the market is segmented into hospitals and home care.

North America accounts for the highest market share followed by Europe. The steep rise in ageing population, advancement in technology, awareness of people and favorable government policies makes U.S. the leader of electroceutical devices market. However, Asian countries especially India and China are the fast growing regions with its growing demand for electroceutical devices.

Major players in Electroceuticals devices market include Boston Scientific (U.S.), St. Jude Medical (U.S), St. Jude Medical (U.S.), Cogentix medical (U.S.), LivaNova (U.K.), Biotronik (Germany), NeuroMetrix (U.S.), Nevro Corporation (U.S.) etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Emergence of electroceuticals as a standalone therapy
3.3.1.2 Increasing r & d investments for electroceuticals research
3.3.1.3 Increasing aging population prone to neurological diseases
3.3.1.4 Cost effective and can be withdrawn when adverse effect is seen
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Side effects and risks associated with the use
3.3.2.2 Availability of alternative treatments
3.3.2.3 Lack of trained professionals
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 CANADA
3.4.5 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 CPT CODES
3.6 PATENT ANALYSIS
3.7 TECHNOLOGICAL ADVANCEMENTS
3.7.1 INTRODUCTION
3.7.2 MINIATURIZATION
3.7.3 WIRELESS MICRO- CURRENT STIMULATION
3.7.4 WEARABLE PAIN MANAGEMENT TECHNOLOGY
3.7.5 MULTI-POINT PACING TECHNOLOGY
3.7.6 INTRANASAL TEAR NEUROSTIMULATOR
3.8 UPCOMING TECHNOLOGY AND PRODUCT LAUNCH
3.9 FUNDING SCENARIO
3.10 ELECTROCEUTICAL DEVICES - DEALS
3.11 CLINICAL TRIAL DATA
3.12 PORTER’S FIVE FORCE ANALYSIS
3.12.1 THREAT OF NEW ENTRANTS
3.12.2 THREAT OF SUBSTITUTES
3.12.3 BARGAINING POWER OF SUPPLIERS
3.12.4 BARGAINING POWER OF BUYERS
3.12.5 RIVALRY AMONG EXISTING COMPETITORS
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 ELECTROCEUTICAL DEVICES GLOBAL MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.1.1 INTERNAL ELECTROCEUTICALS
4.1.1.1 Spinal Cord Stimulation (SCS)
4.1.1.2 Deep Brain Stimulation (DBS)
4.1.1.3 Vagus Nerve Stimulation (VNS)
4.1.1.4 Sacral Nerve Stimulation(SNS)
4.1.1.5 Internal pacemakers
4.1.1.6 Implantable Cardioverter Defibrillator (ICDS)
4.1.1.7 Electric Acoustic Stimulation(EAS)
4.1.1.8 Others
4.1.1.8.1 Gastric Electric Stimulation (GES)
4.1.1.8.2 Respiratory Electrical Stimulation (RES)/Phrenic Nerve Stimulation
4.1.2 EXTERNAL ELECTROCEUTICALS
4.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
4.1.2.2 External pacemakers
4.1.2.3 External & wearable defibrillators
4.1.2.4 Others
4.1.2.4.1 Tumor Treating Fields(TTFIELDS)
4.1.2.4.2 Micro-Current Stimulation
5 ELECTROCEUTICAL DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 PAIN MANAGEMENT
5.2.1 CHRONIC PAIN
5.2.2 FAILED BACK SURGERY SYNDROME (FBSS)
5.2.3 MIGRAINE
5.2.4 ISCHEMIA
5.3 CENTRAL NERVOUS SYSTEM
5.3.1 PARKINSON’S DISEASE
5.3.2 ESSENTIAL TREMORS
5.3.3 DYSTONIA
5.3.4 EPILEPSY OR SEIZURE
5.3.5 DEPRESSION
5.3.6 OBSESSIVE COMPULSIVE DISORDER (OCD)
5.4 GASTROENTEROLOGY AND UROLOGY
5.4.1 GASTROPARESIS
5.4.2 URINARY INCONTINENCE
5.4.3 FAECAL INCONTINENCE
5.5 HEARING AID (OTOLOGY)
5.6 CARDIOLOGY
5.6.1 ATRIAL FIBRILLATION
5.6.2 VENTRICULAR FIBRILLATION
5.6.3 OTHER CARDIOLOGY
5.7 OTHERS
5.7.1 BONE GROWTH STIMULATION
5.7.2 DIAPHRAGM PACING / RESPIRATORY STIMULATION
5.7.3 DIABETES
5.7.4 OBESITY
5.7.5 WOUND CARE
5.7.6 ONCOLOGY
6 ELECTROCEUTICAL DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME CARE
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 ASIA - PACIFIC
7.5 REST OF THE WORLD
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 NEW PRODUCT LAUNCHES
8.4 OTHERS
8.5 AGREEMENTS, COLLOBORATIONS & PARTNERSHIP
8.6 MERGERS & ACQUISITIONS
9 MAJOR COMPANIES
9.1 BIOTRONIK SE & CO.KG
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 BOSTON SCIENTIFIC CORPOARTION
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 COCHLEAR LTD.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 DJO GLOBAL, INC.
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 ENTEROMEDICS INC.
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 LIVANOVA
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 MEDTRONIC, PLC
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 NEUROMETRIX, INC
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 NEVRO CORP.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 PHILIPS HEALTHCARE
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 ST.JUDE MEDICAL, INC.
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report